Vir Biotechnology, Inc.
VIR
$6.12
-$0.17-2.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -521.96M | -533.34M | -483.04M | -539.44M | -615.06M |
| Total Depreciation and Amortization | 14.56M | 16.15M | 17.84M | 18.33M | 19.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.06M | 150.30M | 161.15M | 156.18M | 121.42M |
| Change in Net Operating Assets | -84.01M | -99.75M | -146.94M | -397.46M | -304.59M |
| Cash from Operations | -446.35M | -466.64M | -450.99M | -762.39M | -778.79M |
| Capital Expenditure | -7.30M | -6.43M | -7.79M | -16.58M | -21.57M |
| Sale of Property, Plant, and Equipment | 3.37M | 917.00K | 912.00K | 533.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 503.30M | 259.33M | 83.14M | 111.02M | 186.20M |
| Cash from Investing | 499.37M | 253.82M | 76.26M | 94.97M | 164.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 22.00K | -4.00K | -3.00K | 0.00 |
| Issuance of Common Stock | 4.55M | 5.07M | 5.34M | 5.68M | 7.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -165.00K | -287.00K | -287.00K | -387.00K | -287.00K |
| Cash from Financing | 4.39M | 4.81M | 5.05M | 5.29M | 7.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.40M | -208.02M | -369.68M | -662.14M | -606.68M |